Theravance Biopharma, Inc. Insider Trading for May 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Theravance Biopharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Theravance Biopharma, Inc. for May 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 23 2018 | TBPH | Theravance Biophar ... | MALKIEL BURTON G | Director | Buy | P | 22.54 | 1,000 | 22,540 | 56,757 | 55.8 K to 56.8 K (+1.79 %) |
May 22 2018 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Payment of Exercise | F | 24.31 | 19,524 | 474,628 | 178,654 | 198.2 K to 178.7 K (-9.85 %) |
May 22 2018 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 24.31 | 67,617 | 1,643,769 | 919,620 | 987.2 K to 919.6 K (-6.85 %) |
May 22 2018 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Payment of Exercise | F | 24.31 | 21,812 | 530,250 | 143,464 | 165.3 K to 143.5 K (-13.20 %) |
May 22 2018 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Payment of Exercise | F | 24.31 | 18,779 | 456,517 | 167,025 | 185.8 K to 167 K (-10.11 %) |
May 22 2018 | TBPH | Theravance Biophar ... | PASQUALONE FRANK | SVP, Chief Comm Ops ... | Payment of Exercise | F | 24.31 | 18,424 | 447,887 | 227,810 | 246.2 K to 227.8 K (-7.48 %) |
May 22 2018 | TBPH | Theravance Biophar ... | HEGDE SHARATHCHANDRA S | SVP, Research | Payment of Exercise | F | 24.31 | 19,103 | 464,394 | 174,258 | 193.4 K to 174.3 K (-9.88 %) |
May 22 2018 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Payment of Exercise | F | 24.31 | 26,991 | 656,151 | 148,962 | 176 K to 149 K (-15.34 %) |
May 22 2018 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 24.31 | 21,230 | 516,101 | 214,792 | 236 K to 214.8 K (-8.99 %) |
May 22 2018 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Sell | S | 24.29 | 10,000 | 242,877 | 236,022 | 246 K to 236 K (-4.06 %) |
May 16 2018 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Grant | A | 0.00 | 33,750 | 0 | 198,178 | 164.4 K to 198.2 K (+20.53 %) |
May 16 2018 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 105,000 | 0 | 987,237 | 882.2 K to 987.2 K (+11.90 %) |
May 16 2018 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Grant | A | 0.00 | 33,750 | 0 | 165,276 | 131.5 K to 165.3 K (+25.66 %) |
May 16 2018 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Grant | A | 0.00 | 33,750 | 0 | 185,804 | 152.1 K to 185.8 K (+22.20 %) |
May 16 2018 | TBPH | Theravance Biophar ... | PASQUALONE FRANK | SVP, Chief Comm Ops ... | Grant | A | 0.00 | 33,750 | 0 | 246,234 | 212.5 K to 246.2 K (+15.88 %) |
May 16 2018 | TBPH | Theravance Biophar ... | HEGDE SHARATHCHANDRA S | SVP, Research | Grant | A | 0.00 | 33,750 | 0 | 193,361 | 159.6 K to 193.4 K (+21.15 %) |
May 16 2018 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Grant | A | 0.00 | 33,750 | 0 | 175,953 | 142.2 K to 176 K (+23.73 %) |
May 16 2018 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Grant | A | 0.00 | 33,750 | 0 | 246,022 | 212.3 K to 246 K (+15.90 %) |
May 03 2018 | TBPH | Theravance Biophar ... | YOUNG WILLIAM D | Director | Option Exercise | A | 24.43 | 6,000 | 146,580 | 6,000 | |
May 03 2018 | TBPH | Theravance Biophar ... | YOUNG WILLIAM D | Director | Grant | A | 0.00 | 8,186 | 0 | 43,310 | 35.1 K to 43.3 K (+23.31 %) |
May 03 2018 | TBPH | Theravance Biophar ... | WHITESIDES GEORGE M | Director | Option Exercise | A | 24.43 | 6,000 | 146,580 | 6,000 | |
May 03 2018 | TBPH | Theravance Biophar ... | WHITESIDES GEORGE M | Director | Grant | A | 0.00 | 8,186 | 0 | 192,578 | 184.4 K to 192.6 K (+4.44 %) |
May 03 2018 | TBPH | Theravance Biophar ... | Smaldone Alsup Laurie | Director | Option Exercise | A | 24.43 | 6,000 | 146,580 | 6,000 | |
May 03 2018 | TBPH | Theravance Biophar ... | Smaldone Alsup Laurie | Director | Grant | A | 0.00 | 8,186 | 0 | 9,962 | 1.8 K to 10 K (+460.92 %) |
May 03 2018 | TBPH | Theravance Biophar ... | RINGROSE PETER S | Director | Option Exercise | A | 24.43 | 6,000 | 146,580 | 6,000 | |
May 03 2018 | TBPH | Theravance Biophar ... | RINGROSE PETER S | Director | Grant | A | 0.00 | 8,186 | 0 | 29,614 | 21.4 K to 29.6 K (+38.20 %) |
May 03 2018 | TBPH | Theravance Biophar ... | O'Connor Donal | Director | Option Exercise | A | 24.43 | 6,000 | 146,580 | 6,000 | |
May 03 2018 | TBPH | Theravance Biophar ... | O'Connor Donal | Director | Grant | A | 0.00 | 8,186 | 0 | 23,186 | 15 K to 23.2 K (+54.57 %) |
May 03 2018 | TBPH | Theravance Biophar ... | Molineaux Susan | Director | Option Exercise | A | 24.43 | 6,000 | 146,580 | 6,000 | |
May 03 2018 | TBPH | Theravance Biophar ... | Molineaux Susan | Director | Grant | A | 0.00 | 8,186 | 0 | 14,186 | 6 K to 14.2 K (+136.43 %) |
May 03 2018 | TBPH | Theravance Biophar ... | MITCHELL DEAN J | Director | Option Exercise | A | 24.43 | 6,000 | 146,580 | 6,000 | |
May 03 2018 | TBPH | Theravance Biophar ... | MITCHELL DEAN J | Director | Grant | A | 0.00 | 8,186 | 0 | 26,186 | 18 K to 26.2 K (+45.48 %) |
May 03 2018 | TBPH | Theravance Biophar ... | MALKIEL BURTON G | Director | Option Exercise | A | 24.43 | 6,000 | 146,580 | 6,000 | |
May 03 2018 | TBPH | Theravance Biophar ... | MALKIEL BURTON G | Director | Grant | A | 0.00 | 8,186 | 0 | 55,757 | 47.6 K to 55.8 K (+17.21 %) |
May 03 2018 | TBPH | Theravance Biophar ... | Gunderson Robert V JR | Director | Option Exercise | A | 24.43 | 6,000 | 146,580 | 6,000 | |
May 03 2018 | TBPH | Theravance Biophar ... | Gunderson Robert V JR | Director | Grant | A | 0.00 | 8,186 | 0 | 43,245 | 35.1 K to 43.2 K (+23.35 %) |
May 03 2018 | TBPH | Theravance Biophar ... | BROSHY ERAN | Director | Option Exercise | A | 24.43 | 6,000 | 146,580 | 6,000 | |
May 03 2018 | TBPH | Theravance Biophar ... | BROSHY ERAN | Director | Grant | A | 0.00 | 8,186 | 0 | 26,186 | 18 K to 26.2 K (+45.48 %) |